ArticleBMJ open2019

Protocol for phase I study of pembrolizumab in combination with Bacillus Calmette-Guérin for patients with high-risk non-muscle invasive bladder cancer.

Marcus L Jamil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.